ABT vs. LH: Abbott Laboratories vs. Labcorp Stock Comparison
How do Abbott Laboratories (ABT) and Labcorp (LH) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Abbott Laboratories (ABT) and Labcorp (LH) both fall under the Health Care Equipment & Services industry group, but ABT is classified in Health Care Equipment & Supplies while LH is classified in Health Care Providers & Services.
| Profile Item | ABT | LH |
|---|---|---|
| Name | Abbott Laboratories | Labcorp Holdings Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Equipment | Health Care Services |
| Market Capitalization | 190.39 billion USD | 29.77 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | March 17, 1980 | March 29, 1990 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | ABT | LH |
|---|---|---|
| Total Return (1Y) | -10.78% | 48.62% |
| Total Return (3Y, Annualized) | 7.79% | 23.39% |
| Total Return (5Y, Annualized) | -0.79% | 10.54% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | ABT | LH |
|---|---|---|
| Volatility (1Y, Annualized) | 28.48% | 24.36% |
| Beta (5Y) | 0.53 | 0.85 |
| Max Drawdown (5Y) | -39.64% | -34.61% |
| Avg. Volume (3M) | 8.74M | 721.05K |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | ABT | LH |
|---|---|---|
| Sharpe Ratio (1Y) | -0.53 | 1.82 |
| Sortino Ratio (1Y) | -0.76 | 2.99 |
Profitability
ROE (TTM)
Both Abbott Laboratories (ABT) at 9.14% and Labcorp (LH) at 11.44% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.
ABT
Health Care Equipment & Services industry group
9.14%
- Max
- 47.61%
- Q3
- 14.36%
- ABT
- 9.14%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
LH
Health Care Equipment & Services industry group
11.44%
- Max
- 47.61%
- Q3
- 14.36%
- LH
- 11.44%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Abbott Laboratories (ABT) at 9.75% retains a top-quartile share of revenue as profit, ahead of Labcorp (LH) at 6.88%, which keeps about the industry-typical share.
ABT
Health Care Equipment & Services industry group
9.75%
- Max
- 29.35%
- ABT
- 9.75%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
LH
Health Care Equipment & Services industry group
6.88%
- Max
- 29.35%
- Q3
- 9.33%
- LH
- 6.88%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Abbott Laboratories (ABT) at 11.66% and Labcorp (LH) at 10.91% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.
ABT
Health Care Equipment & Services industry group
11.66%
- Max
- 35.43%
- Q3
- 14.14%
- ABT
- 11.66%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
LH
Health Care Equipment & Services industry group
10.91%
- Max
- 35.43%
- Q3
- 14.14%
- LH
- 10.91%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | ABT | LH |
|---|---|---|
| ROE (TTM) | 9.14% | 11.44% |
| ROA (TTM) | 4.90% | 5.48% |
| Net Margin (TTM) | 9.75% | 6.88% |
| Operating Margin (TTM) | 11.66% | 10.91% |
| Gross Margin (TTM) | 57.17% | 28.96% |
Growth
Revenue Growth
Both Abbott Laboratories (ABT) at 5.67% and Labcorp (LH) at 7.25% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Labcorp (LH) at 18.33% is around its peer norm for EPS growth, while Abbott Laboratories (ABT) at -51.31% drops into the bottom quartile, signaling weaker earnings momentum.
Growth Metrics
| Metric | ABT | LH |
|---|---|---|
| Revenue Growth (YoY) | 5.67% | 7.25% |
| Revenue Growth (3Y CAGR) | 0.51% | 5.55% |
| EPS Growth (YoY) | -51.31% | 18.33% |
| EPS Growth (3Y CAGR) | -1.65% | -9.19% |
Financial Strength
Current Ratio (MRQ)
Both Abbott Laboratories (ABT) at 1.46 and Labcorp (LH) at 1.41 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
ABT
Health Care Equipment & Services industry group
1.46
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- ABT
- 1.46
- Q1
- 1.37
- Min
- 0.30
LH
Health Care Equipment & Services industry group
1.41
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- LH
- 1.41
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Abbott Laboratories (ABT) at 0.61 and Labcorp (LH) at 0.77 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
ABT
Health Care Equipment & Services industry group
0.61
- Max
- 1.88
- Q3
- 0.91
- ABT
- 0.61
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
LH
Health Care Equipment & Services industry group
0.77
- Max
- 1.88
- Q3
- 0.91
- LH
- 0.77
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | ABT | LH |
|---|---|---|
| Current Ratio (MRQ) | 1.46 | 1.41 |
| Debt / Equity (MRQ) | 0.61 | 0.77 |
| Net Debt / EBITDA | 2.37 | 2.81 |
Dividends
Dividend Yield (TTM)
Both Abbott Laboratories (ABT) at 2.22% and Labcorp (LH) at 0.79% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.
ABT
Health Care Equipment & Services industry group
2.22%
- ABT
- 2.22%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LH
Health Care Equipment & Services industry group
0.79%
- LH
- 0.79%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both Abbott Laboratories (ABT) at 92.54% and Labcorp (LH) at 23.61% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.
ABT
Health Care Equipment & Services industry group
92.54%
- ABT
- 92.54%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LH
Health Care Equipment & Services industry group
23.61%
- LH
- 23.61%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | ABT | LH |
|---|---|---|
| Dividend Yield (TTM) | 2.22% | 0.79% |
| Dividend Payout Ratio (TTM) | 92.54% | 23.61% |
Valuation
P/E Ratio (TTM)
Both Abbott Laboratories (ABT) at 41.02 and Labcorp (LH) at 30.05 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
ABT
Health Care Equipment & Services industry group
41.02
- Max
- 80.41
- Q3
- 47.62
- ABT
- 41.02
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
LH
Health Care Equipment & Services industry group
30.05
- Max
- 80.41
- Q3
- 47.62
- LH
- 30.05
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
On P/S ratio, both Abbott Laboratories (ABT) at 3.95 and Labcorp (LH) at 2.04 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
ABT
Health Care Equipment & Services industry group
3.95
- Max
- 8.80
- Q3
- 4.32
- ABT
- 3.95
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
LH
Health Care Equipment & Services industry group
2.04
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- LH
- 2.04
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Abbott Laboratories (ABT) at 3.73 and Labcorp (LH) at 3.36 are valued close to their industries’ norm against book — neither stands out from peers.
ABT
Health Care Equipment & Services industry group
3.73
- Max
- 11.68
- Q3
- 6.12
- ABT
- 3.73
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
LH
Health Care Equipment & Services industry group
3.36
- Max
- 11.68
- Q3
- 6.12
- LH
- 3.36
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | ABT | LH |
|---|---|---|
| P/E Ratio (TTM) | 41.02 | 30.05 |
| P/S Ratio (TTM) | 3.95 | 2.04 |
| P/B Ratio (MRQ) | 3.73 | 3.36 |
| Free Cash Flow Yield (TTM) | 3.19% | 3.55% |